XML 35 R11.htm IDEA: XBRL DOCUMENT v2.4.0.6
Fair Value Measurements
12 Months Ended
Dec. 31, 2011
Fair Value Measurements
Note 4. Fair Value Measurements

The Company measures certain financial assets at fair value on a recurring basis, including cash equivalents, short-term investments, and equity investments. The fair value of these financial assets was determined based on three levels of inputs:

 

   

Level 1: Observable inputs such as quoted prices in active markets for identical assets or liabilities

 

   

Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly; these include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active

 

   

Level 3: Unobservable inputs that reflect the Company’s own assumptions

 

Items Measured at Fair Value on a Recurring Basis

The following table presents information about the Company’s financial assets that have been measured at fair value (in thousands) on a recurring basis as of December 31, 2011 and 2010 and indicates the fair value hierarchy of the valuation inputs utilized to determine such fair value.

 

     Fair Value Measurements as of
December 31, 2011
 
     Total      Level 1      Level 2      Level 3  
     (In thousands)  

Cash equivalents

           

Money market funds

   $ 6,544       $ 6,544       $       $   

Corporate notes and bonds

     20,697         20,697                   

Short-term investments

           

Corporate notes and bonds

     39,254         39,254                   

U.S. government agency securities

     39,485         39,485                   

Restricted cash

     10,168         10,168                   

Equity investments

           

Publicly traded investments

     37,204         37,204                   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 153,352       $ 153,352       $       $   
  

 

 

    

 

 

    

 

 

    

 

 

 
     Fair Value Measurements as of
December 31, 2010
 
     Total      Level 1      Level 2      Level 3  
     (In thousands)  

Cash equivalents

           

Money market funds

   $ 44,348       $ 44,348       $       $   

Corporate notes and bonds

     120,984         120,984                   

U.S. government agency securities

     3,700         3,700                   

Short-term investments

           

Corporate notes and bonds

     76,157         76,157                   

U.S. government agency securities

     22,146         22,146                   

Restricted cash

     10,000         10,000                   

Equity investments

           

Publicly traded investments

     27,541         27,541                   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 304,876       $ 304,876       $       $   
  

 

 

    

 

 

    

 

 

    

 

 

 

Investments in marketable securities classified as short-term investments and equity investments of public companies are measured at fair value using quoted market prices and are classified within Level 1 of the valuation hierarchy. The Company carries its equity investments in private companies at cost and no fair value is derived on a recurring basis.

Items Measured at Fair Value on a Nonrecurring Basis

Certain assets and liabilities of the Company are measured at estimated fair value on a non-recurring basis. These assets and liabilities are subject to fair value adjustments only in certain circumstances (for example, when there is evidence of impairment). The Company performed a valuation using Level 3 inputs of its investment in the Rhapsody joint venture as of March 31, 2010. The Company performed the analysis as a result of the restructuring and related deconsolidation of Rhapsody, which is further described in Note 3, Rhapsody Joint Venture. The fair value analysis used multiple valuation models and was based on assumptions of future results made by management, including operating and cash flow projections.

The Company also performed a valuation of its goodwill as of June 30, 2009 using Level 3 inputs and recorded goodwill impairment charges of $175.6 million during the quarter ended June 30, 2009. See Note 10, Goodwill, for additional information.

See Note 7, Deferred Costs, for a description of the $20.0 million impairment charge for deferred project costs in the quarter ended December 31, 2011.